Stroke-recovery device using brain-computer interface receives FDA market authorization

Innovative multidisciplinary research at Washington University led to development of 'breakthrough' device A first-of-its kind device that helps people disabled by stroke regain significant control over their arm and hand function by using their minds has received market authorization from the Food and Drug Administration (FDA). The IpsiHand Upper Extremity Rehabilitation System, developed by Neurolutions Inc. – a Washington University in St. Louis startup company – leverages brain-computer interface (BCI) technology licensed from the university.